Sanuwave Health Return on Investment 2010-2025 | SNWV
Current and historical return on investment (ROI) values for Sanuwave Health (SNWV) over the last 10 years.
| Sanuwave Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $0.01B | 0.00% | |
| 2024-12-31 | $0.01B | 0.00% | |
| 2024-09-30 | $0.00B | 0.00% | |
| 2024-06-30 | $0.00B | 0.00% | |
| 2024-03-31 | $0.00B | 0.00% | |
| 2023-12-31 | $0.00B | 7.55% | |
| 2023-09-30 | $0.00B | 22.64% | |
| 2023-06-30 | $0.00B | 30.19% | |
| 2023-03-31 | $-0.01B | $-0.05B | 37.21% |
| 2022-12-31 | $-0.01B | 45.71% | |
| 2022-09-30 | $-0.01B | 33.33% | |
| 2022-06-30 | $-0.01B | $-0.03B | 29.20% |
| 2022-03-31 | $-0.01B | $-0.04B | 34.38% |
| 2021-12-31 | $-0.01B | $-0.04B | 49.06% |
| 2021-09-30 | $-0.02B | $-0.03B | 117.07% |
| 2021-06-30 | $-0.03B | $-0.02B | 211.76% |
| 2021-03-31 | $-0.03B | $-0.02B | 253.66% |
| 2020-12-31 | $-0.03B | $-0.01B | 263.16% |
| 2020-09-30 | $-0.02B | $0.00B | 250.00% |
| 2020-06-30 | $-0.01B | $-0.01B | 169.23% |
| 2020-03-31 | $-0.01B | $-0.01B | 333.33% |
| 2019-12-31 | $-0.01B | 0.00% | |
| 2019-09-30 | $-0.01B | 0.00% | |
| 2019-06-30 | $-0.01B | 0.00% | |
| 2019-03-31 | $-0.01B | 0.00% | |
| 2018-12-31 | $-0.01B | 0.00% | |
| 2018-09-30 | $-0.01B | 0.00% | |
| 2018-06-30 | $-0.01B | 500.00% | |
| 2018-03-31 | $0.00B | 400.00% | |
| 2017-12-31 | $0.00B | 266.67% | |
| 2017-09-30 | $0.00B | $0.00B | 266.67% |
| 2017-06-30 | $0.00B | 800.00% | |
| 2017-03-31 | $0.00B | $0.00B | 533.33% |
| 2016-12-31 | $0.00B | 1600.00% | |
| 2016-09-30 | $0.00B | $0.00B | 800.00% |
| 2016-06-30 | $0.00B | $0.00B | 800.00% |
| 2016-03-31 | $0.00B | 0.00% | |
| 2015-12-31 | $0.00B | $0.00B | 0.00% |
| 2015-09-30 | $0.00B | $0.00B | -1600.00% |
| 2015-06-30 | $0.00B | $0.00B | -1600.00% |
| 2015-03-31 | $-0.01B | -333.33% | |
| 2014-12-31 | $-0.01B | -184.62% | |
| 2014-09-30 | $-0.01B | -200.00% | |
| 2014-06-30 | $-0.01B | $0.01B | -254.55% |
| 2014-03-31 | $-0.01B | $0.01B | 2800.00% |
| 2013-12-31 | $-0.01B | $0.00B | 171.43% |
| 2013-09-30 | $-0.01B | $0.00B | 200.00% |
| 2013-06-30 | $-0.01B | $-0.01B | 184.62% |
| 2013-03-31 | $-0.01B | $-0.01B | 333.33% |
| 2012-12-31 | $-0.01B | $0.00B | -1200.00% |
| 2012-09-30 | $-0.01B | $0.00B | -342.86% |
| 2012-06-30 | $-0.01B | $0.00B | -215.38% |
| 2012-03-31 | $-0.01B | $0.00B | -160.00% |
| 2011-12-31 | $-0.01B | $0.00B | -213.33% |
| 2011-09-30 | $-0.01B | $0.01B | -666.67% |
| 2011-06-30 | $-0.01B | $0.01B | 571.43% |
| 2011-03-31 | $-0.01B | $0.00B | 275.00% |
| 2010-12-31 | $-0.01B | $-0.01B | 400.00% |
| 2010-09-30 | $-0.01B | $-0.01B | 1100.00% |
| 2010-06-30 | $-0.01B | $0.00B | -600.00% |
| 2010-03-31 | $-0.01B | $0.00B | -444.44% |
| 2009-12-31 | $-0.01B | $0.00B | -450.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.268B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |